3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      DNA-Polylactide Modified Biosensor for Electrochemical Determination of the DNA-Drugs and Aptamer-Aflatoxin M1 Interactions

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          DNA sensors were assembled by consecutive deposition of thiacalix[4]arenes bearing oligolactic fragments, poly(ethylene imine), and DNA onto the glassy carbon electrode. The assembling of the layers was monitored with scanning electron microscopy, cyclic voltammetry and electrochemical impedance spectroscopy. The configuration of the thiacalix[4]arene core determined self-assembling of the polymeric species to the nano/micro particles with a size of 70–350 nm. Depending on the granulation, the coatings show the accumulation of a variety of DNA quantities, charges, and internal pore volumes. These parameters were used to optimize the DNA sensors based on these coatings. Thus, doxorubicin was determined to have limits of detection of 0.01 nM ( cone configuration), 0.05 nM ( partial cone configuration), and 0.10 nM ( 1,3-alternate configuration of the macrocycle core). Substitution of native DNA with aptamer specific to aflatoxin M1 resulted in the detection of the toxin in the range of 20 to 200 ng/L (limit of detection 5 ng/L). The aptasensor was tested in spiked milk samples and showed a recovery of 80 and 85% for 20 and 50 ng/L of the aflatoxin M1, respectively.

          Related collections

          Most cited references57

          • Record: found
          • Abstract: found
          • Article: not found

          Electrochemical DNA sensors.

          Electrochemistry-based sensors offer sensitivity, selectivity and low cost for the detection of selected DNA sequences or mutated genes associated with human disease. DNA-based electrochemical sensors exploit a range of different chemistries, but all take advantage of nanoscale interactions between the target in solution, the recognition layer and a solid electrode surface. Numerous approaches to electrochemical detection have been developed, including direct electrochemistry of DNA, electrochemistry at polymer-modified electrodes, electrochemistry of DNA-specific redox reporters, electrochemical amplifications with nanoparticles, and electrochemical devices based on DNA-mediated charge transport chemistry.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology.

            Self-assembled peptide and protein amyloid nanostructures have traditionally been considered only as pathological aggregates implicated in human neurodegenerative diseases. In more recent times, these nanostructures have found interesting applications as advanced materials in biomedicine, tissue engineering, renewable energy, environmental science, nanotechnology and material science, to name only a few fields. In all these applications, the final function depends on: (i) the specific mechanisms of protein aggregation, (ii) the hierarchical structure of the protein and peptide amyloids from the atomistic to mesoscopic length scales and (iii) the physical properties of the amyloids in the context of their surrounding environment (biological or artificial). In this review, we will discuss recent progress made in the field of functional and artificial amyloids and highlight connections between protein/peptide folding, unfolding and aggregation mechanisms, with the resulting amyloid structure and functionality. We also highlight current advances in the design and synthesis of amyloid-based biological and functional materials and identify new potential fields in which amyloid-based structures promise new breakthroughs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              DNA and its associated processes as targets for cancer therapy.

              DNA is the molecular target for many of the drugs that are used in cancer therapeutics, and is viewed as a non-specific target of cytotoxic agents. Although this is true for traditional chemotherapeutics, other agents that were discovered more recently have shown enhanced efficacy. Furthermore, a new generation of agents that target DNA-associated processes are anticipated to be far more specific and effective. How have these agents evolved, and what are their molecular targets?
                Bookmark

                Author and article information

                Journal
                Sensors (Basel)
                Sensors (Basel)
                sensors
                Sensors (Basel, Switzerland)
                MDPI
                1424-8220
                14 November 2019
                November 2019
                : 19
                : 22
                : 4962
                Affiliations
                [1 ]A.M. Butlerov’ Chemistry Institute of Kazan Federal University, 18 Kremlevskaya Street, 420008 Kazan, Russian; veronika1287@ 123456yandex.ru (V.S.); vas1993@ 123456yandex.ru (V.S.); leongard87@ 123456mail.ru (V.G.); Ivan.Stoikov@ 123456mail.ru (I.S.); gennady.evtugyn@ 123456kpfu.ru (G.E.)
                [2 ]Department of Nuclear Physics and Biophysics, Comenius University, Mlynska dolina F1, 842 48 Bratislava, Slovakia
                Author notes
                [* ]Correspondence: tibor.hianik@ 123456fmph.uniba.sk ; Tel.: +421-2-6029-5683
                Author information
                https://orcid.org/0000-0002-3019-7866
                https://orcid.org/0000-0002-5906-0548
                Article
                sensors-19-04962
                10.3390/s19224962
                6891816
                31739501
                f78d2ab0-cc9b-4594-be0d-4bc90b6519f5
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 30 September 2019
                : 11 November 2019
                Categories
                Article

                Biomedical engineering
                oligolactides,electrochemical dna sensor,dna aptamer,aflatoxin m1,self-assembling,phenothiazine dyes

                Comments

                Comment on this article